8 results on '"Kim, Tae‐Gyu"'
Search Results
2. Effect of high-dose radiation therapy on positive margins after breast-conserving surgery for invasive breast cancer.
- Author
-
Kim, Hyunjung, Kim, Tae Gyu, Park, Byungdo, Kim, Jeong Ho, Jun, Si-Youl, Lee, Jun Ho, Choi, Hee Jun, Jung, Chang Shin, Bang, Yoon Ju, Lee, Hyoun Wook, Lee, Jae Seok, Nam, Hyun Yeol, Shin, Seunghyeon, Kim, Sung Min, and Kim, Haeyoung
- Subjects
BREAST cancer surgery ,RADIOTHERAPY ,LUMPECTOMY ,OLDER patients ,SURVIVAL rate - Abstract
Positive margins after breast-conserving surgery are associated with poor oncological outcomes and warrant additional surgery. This study aimed to evaluate the effectiveness of high-dose radiation therapy for positive margins by comparing local recurrence between patients with positive and negative margins. We retrospectively evaluated 550 patients treated with adjuvant radiation therapy after breast-conserving surgery for invasive breast cancer between 2013 and 2019. The total equivalent dose in 2 Gy fractions (EQD2) to the tumor bed ranged from 65.81 to 66.25 Gy for positive margins and 59.31–61.81 Gy for negative margins. The differences in local recurrence between the positive and negative margin groups were analyzed. After a median follow-up of 58 months, the crude local recurrence rate was 7.3% in the positive margin group (n = 55) and 2.4% in the negative margin group (n = 495). Positive margins were associated with higher local recurrence without statistical significance in the entire cohort (p = 0.062). Among patients aged <60 years, those with positive margins had a significantly lower 5-year local recurrence-free survival rate than those with negative margins (89.16% vs. 97.57%, respectively; p = 0.005). In contrast, there was no significant difference in the 5-year local recurrence-free survival rate between patients with positive and negative margins among those aged ≥60 years (100.00% vs. 94.38%, respectively; p = 0.426). In this study, positive margins were not associated with poor local control in older patients after a high-dose boosts. Further prospective studies are needed to verify our findings. • Positive margins are known to be related to poor local control in breast cancer. • In this study, positive margins were not related to local control in older patients. • High-dose boost may lessen adverse effects of positive margins in older patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06).
- Author
-
Park, Younghee, Shin, Young Seob, Kim, Kyubo, Shin, Kyung Hwan, Chang, Ji Hyun, Kim, Su Ssan, Jung, Jin Hong, Park, Won, Kim, Haeyoung, Kim, Yong Bae, Ahn, Sung Ja, Kim, Myungsoo, Kim, Jin Hee, Cha, Hye Jung, Kim, Tae Gyu, Park, Hae Jin, and Lee, Sun Young
- Subjects
AXILLARY lymph node dissection ,NEOADJUVANT chemotherapy ,SENTINEL lymph node biopsy ,BREAST cancer ,PROPENSITY score matching ,CANCER prognosis - Abstract
We evaluated the impact of omitting axillary lymph node dissection (ALND) on oncological outcomes in breast cancer patients with residual nodal disease after neoadjuvant chemotherapy (NAC). The medical records of patients who underwent NAC followed by surgical resection and had residual nodal disease were retrospectively reviewed. In total, 1273 patients from 12 institutions were included; all underwent postoperative radiotherapy. Axillary surgery consisted of ALND in 1103 patients (86.6%) and sentinel lymph node biopsy (SLNBx) alone in 170 (13.4%). Univariate and multivariate analyses of disease-free survival (DFS) and overall survival (OS) were performed before and after propensity score matching (PSM). The median follow-up was 75.3 months (range, 2.5–182.7). Axillary recurrence rates were 4.8% in the ALND group (n = 53) and 4.7% in the SLNBx group (n = 8). Before PSM, univariate analysis indicated that the 5-year OS rate was inferior in the ALND group compared to the SLNBx group (86.6% vs. 93.3%, respectively; P = 0.002); multivariate analysis did not show a difference between groups (P = 0.325). After PSM, 258 and 136 patients were included in the ALND and SLNBx groups, respectively. There were no significant differences between the ALND and SLNBx groups in DFS (5-year rate, 75.8% vs. 76.9%, respectively; P = 0.406) or OS (5-year rate, 88.7% vs. 93.1%, respectively; P = 0.083). SLNBx alone did not compromise oncological outcomes in patients with residual nodal disease after NAC. The omission of ALND might be a possible option for axillary management in patients treated with NAC and postoperative radiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Correlation Between 18F-FDG Uptake and Immune Cell Infiltration in Metastatic Brain Lesions.
- Author
-
An, Young-Sil, Kim, Se-Hyuk, Roh, Tae Hoon, Park, So Hyun, Kim, Tae-Gyu, and Kim, Jang-Hee
- Subjects
BRAIN damage ,BRAIN imaging ,POSITRON emission tomography ,BREAST cancer ,METASTASIS ,BRAIN metastasis - Abstract
Background: The purpose of this study was to investigate the correlation between
18 F-fluorodeoxyglucose (FDG) uptake and infiltrating immune cells in metastatic brain lesions. Methods: This retrospective study included 34 patients with metastatic brain lesions who underwent brain18 F-FDG positron emission tomography (PET)/computed tomography (CT) followed by surgery.18 F-FDG uptake ratio was calculated by dividing the standardized uptake value (SUV) of the metastatic brain lesion by the contralateral normal white matter uptake value. We investigated the clinicopathological characteristics of the patients and analyzed the correlation between18 F-FDG uptake and infiltration of various immune cells. In addition, we evaluated immune-expression levels of glucose transporter 1 (GLUT1), hexokinase 2 (HK2), and Ki-67 in metastatic brain lesions. Results: The degree of18 F-FDG uptake of metastatic brain lesions was not significantly correlated with clinical parameters. There was no significant relationship between the18 F-FDG uptake and degree of immune cell infiltration in brain metastasis. Furthermore, other markers, such as GLUT1, HK2, and Ki-67, were not correlated with degree of18 F-FDG uptake. In metastatic brain lesions that originated from breast cancer, a higher degree of18 F-FDG uptake was observed in those with high expression of CD68. Conclusions: In metastatic brain lesions, the degree of18 F-FDG uptake was not significantly associated with infiltration of immune cells. The18 F-FDG uptake of metastatic brain lesions from breast cancer, however, might be associated with macrophage activity. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
5. Corrigendum to 'Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study' [The Breast 73 (2024) 103599].
- Author
-
Choi, Min Seo, Chang, Jee Suk, Kim, Kyubo, Kim, Jin Hee, Kim, Tae Hyung, Kim, Sungmin, Cha, Hyejung, Cho, Oyeon, Choi, Jin Hwa, Kim, Myungsoo, Kim, Juree, Kim, Tae Gyu, Yeo, Seung-Gu, Chang, Ah Ram, Ahn, Sung-Ja, Choi, Jinhyun, Kang, Ki Mun, Kwon, Jeanny, Koo, Taeryool, and Kim, Mi Young
- Subjects
BREAST cancer ,AUTOETHNOGRAPHY - Published
- 2024
- Full Text
- View/download PDF
6. Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study.
- Author
-
Choi, Min Seo, Chang, Jee Suk, Kim, Kyubo, Kim, Jin Hee, Kim, Tae Hyung, Kim, Sungmin, Cha, Hyejung, Cho, Oyeon, Choi, Jin Hwa, Kim, Myungsoo, Kim, Juree, Kim, Tae Gyu, Yeo, Seung-Gu, Chang, Ah Ram, Ahn, Sung-Ja, Choi, Jinhyun, Kang, Ki Mun, Kwon, Jeanny, Koo, Taeryool, and Kim, Mi Young
- Subjects
BREAST cancer ,HIERARCHICAL clustering (Cluster analysis) ,AUTOETHNOGRAPHY ,DEEP learning ,CLUSTER analysis (Statistics) ,RADIOTHERAPY - Abstract
To quantify interobserver variation (IOV) in target volume and organs-at-risk (OAR) contouring across 31 institutions in breast cancer cases and to explore the clinical utility of deep learning (DL)-based auto-contouring in reducing potential IOV. In phase 1, two breast cancer cases were randomly selected and distributed to multiple institutions for contouring six clinical target volumes (CTVs) and eight OAR. In Phase 2, auto-contour sets were generated using a previously published DL Breast segmentation model and were made available for all participants. The difference in IOV of submitted contours in phases 1 and 2 was investigated quantitatively using the Dice similarity coefficient (DSC) and Hausdorff distance (HD). The qualitative analysis involved using contour heat maps to visualize the extent and location of these variations and the required modification. Over 800 pairwise comparisons were analysed for each structure in each case. Quantitative phase 2 metrics showed significant improvement in the mean DSC (from 0.69 to 0.77) and HD (from 34.9 to 17.9 mm). Quantitative analysis showed increased interobserver agreement in phase 2, specifically for CTV structures (5–19 %), leading to fewer manual adjustments. Underlying IOV differences causes were reported using a questionnaire and hierarchical clustering analysis based on the volume of CTVs. DL-based auto-contours improved the contour agreement for OARs and CTVs significantly, both qualitatively and quantitatively, suggesting its potential role in minimizing radiation therapy protocol deviation. • We investigated the utility of a breast cancer deep-learning auto-contouring model. • Greater interobserver agreement in target volume and organs-at-risk was achieved. • Deep-learning models may reduce clinical trial radiation therapy protocol deviation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer.
- Author
-
Yim, Hyun Ee, Kim, Jang-Hee, Ahn, Mi Sun, Jung, Yongsik, Roh, Jin, Park, So Hyun, Kim, Tae-Gyu, Choi, Jin-Hyuk, and Kang, Seok Yun
- Subjects
BREAST cancer ,MUCINOUS adenocarcinoma ,LYMPHATIC metastasis ,CASE studies ,CANCER invasiveness - Abstract
Pure mucinous breast carcinoma (PMBC) is characterized by clusters of tumor cells floating in abundant extracellular mucin and can be classified into paucicellular (Type A) and hypercellular (Type B) subtypes. However, the clinicopathological and genomic differences between these two subtypes have not been well characterized. We retrospectively investigated the clinicopathologic features of 45 cases of surgically removed PMBC (31 Type A and 14 Type B). We also performed whole-exome sequencing (WES) in eight cases of PMBC. We found that Type B PMBC occurs at an older age and shows more aggressive clinical behavior than Type A. WES analysis revealed that HYDIN was the most frequently mutated gene in both types of PMBC. Although Type B PMBC showed a tendency toward more frequent genetic alterations, there were no statistically significant differences between the two subtypes in single nucleotide variants or insertions or deletions of bases associated with moderate or high effects. Our results provide additional evidence that PMBCs are clinicopathologically and genetically heterogeneous and lack pathognomonic genetic alterations. Further, Type B PMBC is more frequently associated with lymph node metastasis than Type A. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701).
- Author
-
Kim, Haeyoung, Kim, Heejung, Park, Won, Baek, Jong Yun, Ahn, Sung Ja, Kim, Mi Young, Park, Shin-Hyung, Lee, Ik Jae, Ha, Inbong, Kim, Jin Hee, Kim, Tae Hyun, Lee, Kyu Chan, Lee, Hyung-Sik, Kim, Tae Gyu, Kim, Jin Ho, Lee, Jong Hoon, Jung, Jinhong, Cho, Oyeon, Chang, Jee Suk, and Kim, Eun Seog
- Subjects
BREAST tumors ,CANCER patients ,LYMPH nodes ,METASTASIS ,RADIATION doses ,RADIATION dosimetry ,STATISTICS ,DATA analysis - Abstract
Simple Summary: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. In all RLN regions including supraclavicular lymph node, axillary lymph node, and internal mammary lymph node, the radiation dose to the RLN was higher in WBI+RNI plan than WBI plan. The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. To compare target coverage between the participants, an isodose line equal to 90% of the prescribed dose was converted to an isodose contour (contour
90% iso ). The relative nodal dose (RND) was obtained using the ratio of RLN dose to the target dose. The Fleiss's kappa values which represent inter-observer agreement of contour90% iso were over 0.68. For RNI, 6 institutions included axillary lymph node (ALN), supraclavicular lymph node (SCN), and internal mammary lymph node (IMN), while 18 hospitals included only ALN and SCN. The median RND between the WBI and WBI+RNI were as follows: 0.64 vs. 1.05 (ALN level I), 0.27 vs. 1.08 (ALN level II), 0.02 vs. 1.12 (ALN level III), 0.01 vs. 1.12 (SCN), and 0.54 vs. 0.82 (IMN). In all nodal regions, the RND was significantly lower in WBI than in WBI+RNI (p < 0.01). In this study, we could identify the nodal dose difference between WBI and WBI+RNI. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.